Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
STAAR Surgical Co (STAA)  
$41.53 0.93 (2.29%) as of 4:30 Fri 5/31


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 51,268,000
Market Cap: 2.13(B)
Last Volume: 302,338 Avg Vol: 591,145
52 Week Range: $27.67 - $58.12
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 7
Insider 6 Months    : 19.5
Insider 3/6 Months : 26.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   STAAR Surgical designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. Co.'s products are implantable Collamer lenses (ICLs) used in refractive surgery and intraocular lenses (IOLs) used in cataract surgery. ICLs, consisting of Co.'s ICL family of products, including the Toric implantable Collamer lenses and EVO+ Visian ICL, are intraocular lenses used to correct refractive conditions such as myopia, hyperopia, astigmatism, and presbyopia. IOLs are prosthetic intraocular lenses used to restore vision that has been affected by cataracts, and include Co.'s lines of silicone IOLs and the Preloaded Injector.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 1,751 233,196 1,992,449 2,183,524
Total Buy Value $66,736 $6,683,993 $69,506,421 $78,567,996
Total People Bought 2 3 5 5
Total Buy Transactions 3 12 54 60
Total Shares Sold 0 0 0 52,830
Total Sell Value $0 $0 $0 $4,470,374
Total People Sold 0 0 0 2
Total Sell Transactions 0 0 0 3
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 906
  Page 14 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China   •       –      –    2020-06-10 4 S $44.00 $34,540 D/D (785) 127,950 -64%     
   Blickensdoerfer Hans-Martin Sr. VP, Comm. Ops, China   •       –      –    2020-06-10 4 OE $11.00 $8,635 D/D 785 128,735     -
   Kliman Gilbert H Director   –       •      –    2020-06-01 4 A $0.00 $0 D/D 464 464     -
   Gesten Samuel J Chief Legal Officer   •       –      –    2020-05-21 4 S $40.00 $7,700,880 D/D (192,522) 41,185 -44%     
   Gesten Samuel J Chief Legal Officer   •       –      –    2020-05-21 4 A $5.34 $2,287,405 D/D 192,522 233,707     -
   Holliday Keith Chief Technology Officer   •       –      –    2020-05-15 4 S $37.69 $942,250 D/D (25,000) 28,447 -55%     
   Holliday Keith Chief Technology Officer   •       –      –    2020-05-15 4 OE $7.20 $180,000 D/D 25,000 53,447     -
   Francese James E Sr. VP, Comm. Ops., NA, APAC   •       –      –    2020-05-13 4 OE $5.34 $35,602 D/D 6,667 51,133     -
   Francese James E Sr. VP, Comm. Ops., NA, APAC   •       –      –    2020-05-11 4 S $39.06 $736,515 D/D (18,856) 44,466 -41%     
   Francese James E Sr. VP, Comm. Ops., NA, APAC   •       –      –    2020-05-11 4 OE $7.35 $227,502 D/D 18,856 63,322     -
   Hansen Graydon C. Sr. VP, Global Operations   •       –      –    2020-05-11 4 S $39.01 $709,708 D/D (18,189) 21,553 -41%     
   Hansen Graydon C. Sr. VP, Global Operations   •       –      –    2020-05-11 4 OE $9.30 $277,019 D/D 20,283 29,972     -
   Hayashida Jon K. VP, Global Clinical, Medical   •       –      –    2020-05-11 4 S $39.11 $1,821,079 D/D (46,563) 10,794 -41%     
   Hayashida Jon K. VP, Global Clinical, Medical   •       –      –    2020-05-11 4 OE $7.52 $394,879 D/D 46,563 57,357     -
   Francese James E Sr. VP, Comm. Ops., NA, APAC   •       –      –    2020-03-23 4 S $26.77 $60,233 D/D (2,250) 44,466 -129%     
   Hayashida Jon K. VP, Global Clinical, Medical   •       –      –    2020-03-23 4 S $26.83 $75,473 D/D (2,813) 10,794 -129%     
   Andrews Deborah J Chief Financial Officer   •       –      –    2020-03-23 4 S $27.42 $22,868 D/D (834) 31,267 -129%     
   Hansen Graydon C. Sr. VP, Global Operations   •       –      –    2020-03-23 4 S $27.42 $77,132 D/D (2,813) 19,459 -129%     
   Gesten Samuel J Chief Legal Officer   •       –      –    2020-03-23 4 S $27.42 $75,186 D/D (2,742) 41,185 -129%     
   Francese James E Sr. VP, Comm. Ops., NA, APAC   •       –      –    2020-03-20 4 A $0.00 $0 D/D 6,913 46,716     -
   Hayashida Jon K. VP, Global Clinical, Medical   •       –      –    2020-03-20 4 A $0.00 $0 D/D 7,357 13,607     -
   Barnes Scott D Chief Medical Officer   •       –      –    2020-03-20 4 A $0.00 $0 D/D 9,358 20,390     -
   Gesten Samuel J Chief Legal Officer   •       –      –    2020-03-20 4 A $0.00 $0 D/D 7,745 42,873     -
   Holliday Keith Chief Technology Officer   •       –      –    2020-03-20 4 A $0.00 $0 D/D 7,874 28,447     -
   Moore John C Director   –       •      –    2020-03-18 4 OE $5.81 $58,100 D/D 10,000 66,422     -
  906 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 14 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us